Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16685221 | 0.93 | APP (0.41) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL3724858 | 0.85 | — | — | |
| SCHEMBL28319228 | 0.83 | PTGS1 (0.36) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL329052 | 0.80 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL25385302 | 0.78 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL966471 | 0.78 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL5144485 | 0.78 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| Ammonia Solution, Strong SCHEMBL18008289 | 0.78 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL25382857 | 0.78 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL28621315 | 0.78 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0625161-B9 | PROCESS FOR RECOVERING A HIGH-PURITY VIRUS-INACTIVATED FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX BY ANION EXCHANGER CHROMATOGRAPHY | OCTAPHARMA AG (CH) | 2007-09-19 | — | — | EP | disclosed |
| EP-0625161-B2 | PROCESS FOR RECOVERING A HIGH-PURITY VIRUS-INACTIVATED FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX BY ANION EXCHANGER CHROMATOGRAPHY | OCTAPHARMA AG (CH) | 2007-05-16 | — | — | EP | disclosed |
| EP-0625161-B1 | PROCESS FOR RECOVERING A HIGH-PURITY VIRUS-INACTIVATED FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX BY ANION EXCHANGER CHROMATOGRAPHY | OCTAPHARMA AG (CH) | 2001-07-18 | — | — | EP | disclosed |
| US-5714590-A | Process for recovering a high-purity virus-inactivated factor VIII by anion exchanger chromatography | OCTAPHARMA AG (CH) | 1998-02-03 | — | — | US | disclosed |
| EP-0625161-A1 | PROCESS FOR RECOVERING A HIGH-PURITY VIRUS-INACTIVATED FACTOR VIII BY ANION EXCHANGER CHROMATOGRAPHY | OCTAPHARMA AG (CH) | 1994-11-23 | — | — | EP | disclosed |
| WO-1993015105-A1 | PROCESS FOR RECOVERING A HIGH-PURITY VIRUS-INACTIVATED FACTOR VIII BY ANION EXCHANGER CHROMATOGRAPHY | OCTAPHARMA AG (CH) | 1993-08-05 | — | — | WO | disclosed |